HDAC6 Inhibitor is a selective and potent inhibitor of HDAC6 (IC50 = 0.002 nM, as compared with HDAC1 (IC50 = 271 nM), HDAC2 (IC50 = 252 nM), HDAC3 (IC50 = 0.42 nM), HDAC8 (IC50 = 6851 nM), and HDAC10 (IC50 = 90.7 nM). HDAC6 Inhibitor also prevents the growth of several pancreatic cancer cell lines (IC50 = 0.1-1 μM). HDAC6 Inhibitor is more active in inhibiting cell growth than the broad spectrum HDAC inhibitor suberoylanilide hydroamic acid (sc-220139).
1. Kozikowski, Alan P., et al., 2008. Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6. Journal of medicinal chemistry. 51(15): 4370-3. PMID: 18642892
See how others have used HDAC6 Inhibitor. Click on the entry to view the PubMed entry .
PMID: # 28767685 Takano, K. et al. 2017. PLoS ONE. 12: e0182291.
PMID: # 27363897 Janjanam, J. et al. 2016. Sci Rep. 6: 28687.
PMID: # 25342559 Yang, Y. et al. 2014. Cell Res. 24: 1342-53.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.